Skip to main content

Advertisement

SpringerLink
Log in

Metabolic syndrome as a predictor of perioperative outcomes in primary bariatric surgery, a MBSAQIP survey

  • Published:
Surgical Endoscopy Aims and scope Submit manuscript

Abstract

Background

Among bariatric surgery patients, body mass index (BMI) does not fully capture the severity of obesity and it may be complicated to stratify patients at higher risk of peri-operative complications. In our study, we surveyed the MBSAQIP database to determine whether bariatric patients with metabolic syndrome (MetS) are at higher risk for peri-operative complications.

Methods

MBSAQIP database was used to investigate the correlation between MetS and perioperative outcomes. All patients between 2015 and 2018, ≥ 18 years old, who underwent primary bariatric surgery were included. Patients were excluded if they underwent natural orifice transluminal endoscopic surgery or had surgery performed by gastroenterologist or interventional radiologist. We modified the International Diabetes Federation definition of MetS for our study to select patients with BMI > 30 in addition to two or more of the following comorbidities: hypertension, hyperlipidemia, or diabetes. The primary outcome was perioperative mortality. Secondary outcomes included post-operative surgical site infections (SSI), perioperative MI, stroke, acute renal failure, transfusion requirement, readmission, conversion to open and reoperation.

Results

Between 2015 and 2018, 760,076 bariatric operations were performed. 670,935 met criteria for analysis. 190,239 patients were identified to have MetS. Patients with MetS were found to have higher odds of death (OR 2.32; 95% CI 1.97–2.72), SSI (OR 1.39; 95% CI 1.31–1.48), perioperative MI (OR 4.70; 95% CI 3.42–6.45), stroke (OR 3.30; 95% CI 2.08–5.24), acute renal failure (OR 3.04; 95% CI 2.48–3.72), and transfusion requirement (OR 1.30; 95% CI 1.33–1.39).

Conclusion

Patients with metabolic syndrome are at increased odds of peri-operative complications after bariatric surgery.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Adapted from Table 1, "IDF Consensus Worldwide Definition of the Metabolic Syndrome." International Diabetes Federation. (2006, updated 7/26/2020). BMI body mass index, BP blood pressure, HDL high-density lipoprotein

Similar content being viewed by others

References

  1. World Health Organization (2020) Obesity and overweight. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight

  2. O’Neill S, O’Driscoll L (2015) Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies. Obes Rev 16:1–12

    Article  CAS  Google Scholar 

  3. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA et al (2009) Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120:1640–1645

    CAS  PubMed  Google Scholar 

  4. Sookoian S, Pirola CJ (2011) Metabolic syndrome: from the genetics to the pathophysiology. Curr Hypertens Rep 13:149–157

    Article  CAS  Google Scholar 

  5. Saklayen MG (2018) The global epidemic of the metabolic syndrome. Curr Hypertens Rep 20:12

    Article  Google Scholar 

  6. Cordero P, Li J, Oben JA (2017) Bariatric surgery as a treatment for metabolic syndrome. J R Coll Physicians Edinb 47:364–368

    Article  CAS  Google Scholar 

  7. Arterburn DE, Bogart A, Sherwood NE, Sidney S, Coleman KJ, Haneuse S et al (2013) A multisite study of long-term remission and relapse of type 2 diabetes mellitus following gastric bypass. Obes Surg 23:93–102

    Article  Google Scholar 

  8. Sjöström L, Peltonen M, Jacobson P, Ahlin S, Andersson-Assarsson J, Anveden Å et al (2014) Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. JAMA 311:2297–2304

    Article  Google Scholar 

  9. Sjöström L, Peltonen M, Jacobson P, Sjöström CD, Karason K, Wedel H et al (2012) Bariatric surgery and long-term cardiovascular events. JAMA 307:56–65

    Article  Google Scholar 

  10. Hanipah ZN, Schauer PR (2020) Bariatric surgery as a long-term treatment for type 2 diabetes/metabolic syndrome. Annu Rev Med 71:1–15

    Article  CAS  Google Scholar 

  11. Batsis JA, Romero-Corral A, Collazo-Clavell ML, Sarr MG, Somers VK, Lopez-Jimenez F (2008) Effect of bariatric surgery on the metabolic syndrome: a population-based, long-term controlled study. Mayo Clin Proc 83:897–906

    Article  Google Scholar 

  12. Du X, Fu XH, Peng BQ, Luo R, Hu JK, Cheng Z (2018) Resolution of metabolic syndrome and related metabolic disorders after bariatric surgery: comparison of sleeve gastrectomy and gastric bypass. Surg Obes Relat Dis 14:1348–1356

    Article  Google Scholar 

  13. Adams TD, Davidson LE, Litwin SE, Kim J, Kolotkin RL, Nanjee MN et al (2017) Weight and metabolic outcomes 12 years after gastric bypass. N Engl J Med 377:1143–1155

    Article  Google Scholar 

  14. Puzziferri N, Roshek TB 3rd, Mayo HG, Gallagher R, Belle SH, Livingston EH (2014) Long-term follow-up after bariatric surgery: a systematic review. JAMA 312:934–942

    Article  CAS  Google Scholar 

  15. Glance LG, Wissler R, Mukamel DB, Li Y, Diachun CA, Salloum R et al (2010) Perioperative outcomes among patients with the modified metabolic syndrome who are undergoing noncardiac surgery. Anesthesiology 113:859–872

    Article  Google Scholar 

  16. Edelstein AI, Lovecchio F, Delagrammaticas DE, Fitz DW, Hardt KD, Manning DW (2017) The impact of metabolic syndrome on 30-day complications following total joint arthroplasty. J Arthroplasty 32:362–366

    Article  Google Scholar 

  17. Selph JP, Whited WM, Smith AB, Matthews J, Pruthi RS, Wallen EM et al (2014) Metabolic syndrome as a predictor for postoperative complications after urologic surgery. Urology 83:1051–1059

    Article  Google Scholar 

  18. Shariq OA, Fruth KM, Hanson KT, Cronin PA, Richards ML, Farley DR et al (2018) Metabolic syndrome is associated with increased postoperative complications and use of hospital resources in patients undergoing laparoscopic adrenalectomy. Surgery 163:167–175

    Article  Google Scholar 

  19. Shariq OA, Hanson KT, McKenna NP, Kelley SR, Dozois EJ, Lightner AL et al (2019) Does metabolic syndrome increase the risk of postoperative complications in patients undergoing colorectal cancer surgery? Dis Colon Rectum 62:849–858

    Article  Google Scholar 

  20. Tanaka A, Perlick A, Miller CC 3rd, Sandhu HK, Afaq S, Safi HJ et al (2018) Metabolic syndrome but not obesity adversely affects outcomes after open aortoiliac bypass surgery. Ann Vasc Surg 46:155–161

    Article  Google Scholar 

  21. Zmistowski B, Dizdarevic I, Jacovides CL, Radcliff KE, Mraovic B, Parvizi J (2013) Patients with uncontrolled components of metabolic syndrome have increased risk of complications following total joint arthroplasty. J Arthroplasty 28:904–907

    Article  Google Scholar 

  22. Surgeons ACo (2019) MBSAQIP standards manual 1996–2021

  23. International Diabetes Federation (2006) IDF consensus worldwide definition of the metabolic syndrome. https://www.idf.org/e-library/consensus-statements/60-idfconsensus-worldwide-definitionof-the-metabolic-syndrome.html. Accessed 18 May 2021

  24. Piché ME, Tchernof A, Després JP (2020) Obesity phenotypes, diabetes, and cardiovascular diseases. Circ Res 126:1477–1500

    Article  Google Scholar 

  25. Csige I, Ujvárosy D, Szabó Z, Lőrincz I, Paragh G, Harangi M et al (2018) The impact of obesity on the cardiovascular system. J Diabetes Res 2018:3407306

    Article  Google Scholar 

  26. Mullen JT, Moorman DW, Davenport DL (2009) The obesity paradox: body mass index and outcomes in patients undergoing nonbariatric general surgery. Ann Surg 250:166–172

    Article  Google Scholar 

  27. Tjeertes EK, Hoeks SE, Beks SB, Valentijn TM, Hoofwijk AG, Stolker RJ (2015) Obesity—a risk factor for postoperative complications in general surgery? BMC Anesthesiol 15:112

    Article  CAS  Google Scholar 

  28. Blüher M (2019) Obesity: global epidemiology and pathogenesis. Nat Rev Endocrinol 15:288–298

    Article  Google Scholar 

  29. Goossens GH (2017) The metabolic phenotype in obesity: fat mass, body fat distribution, and adipose tissue function. Obes Facts 10:207–215

    Article  CAS  Google Scholar 

  30. Lak KL, Helm MC, Kindel TL, Gould JC (2019) Metabolic syndrome is a significant predictor of postoperative morbidity and mortality following bariatric surgery. J Gastrointest Surg 23:739–744

    Article  Google Scholar 

  31. Varela JE, Hinojosa MW, Nguyen NT (2008) Bariatric surgery outcomes in morbidly obese with the metabolic syndrome at US academic centers. Obes Surg 18:1273–1277

    Article  Google Scholar 

  32. Purnell JQ, Selzer F, Smith MD, Berk PD, Courcoulas AP, Inabnet WB et al (2014) Metabolic syndrome prevalence and associations in a bariatric surgery cohort from the longitudinal assessment of bariatric surgery-2 study. Metab Syndr Relat Disord 12:86–94

    Article  Google Scholar 

  33. Inabnet WB 3rd, Winegar DA, Sherif B, Sarr MG (2012) Early outcomes of bariatric surgery in patients with metabolic syndrome: an analysis of the bariatric outcomes longitudinal database. J Am Coll Surg 214:550–556

    Article  Google Scholar 

Download references

Funding

Non-funded research.

Author information

Authors and Affiliations

  1. Department of Surgery, Warren Alpert Medical School of Brown University, Providence, RI, USA

    Matthew J. Sarna, Marcoandrea Giorgi & Andrew R. Luhrs

  2. Department of Surgery, Brown University/Rhode Island Hospital, APC 4, 593 Eddy Street, Providence, RI, 02903, USA

    Matthew J. Sarna

Authors
  1. Matthew J. Sarna
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marcoandrea Giorgi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Andrew R. Luhrs
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Matthew J. Sarna.

Ethics declarations

Disclosures

The author Matthew Sarna declares no conflict of interest for this research. Andrew Luhrs serves as a consultant for Medtronic, Bard Davol, and Activ Surgical. Marcoandrea Giorgi’s spouse is currently employed as a regulatory manager at BD medical technology company.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sarna, M.J., Giorgi, M. & Luhrs, A.R. Metabolic syndrome as a predictor of perioperative outcomes in primary bariatric surgery, a MBSAQIP survey. Surg Endosc 36, 6122–6128 (2022). https://doi.org/10.1007/s00464-021-08954-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00464-021-08954-5

Keywords

Search

Navigation